R&D channel feed

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

Last month
Pharma

Chi­na start­up in­jects CRISPR ther­a­py in­to the brain for the first time

Last month
Startups
China

Trodelvy and Keytru­da com­bo suc­ceeds in Phase 3 breast can­cer study

Last month

Roivant brings rare dis­ease pro­gram clos­er as Im­muno­vant CEO re­tires

Last month
People

Roche dis­con­tin­ues low dose in Hunt­ing­ton’s tri­al, will switch pa­tients to high dose

Last month

Nether­lands pours $1.5B in­to biotech in pur­suit of glob­al lead­er­ship am­bi­tions

Last month
Financing

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Last month

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

Last month

Gly­comine rais­es $115M to see if it can treat rare gly­co­sy­la­tion dis­or­der

Last month
Financing
Startups

Mur­al On­col­o­gy ends clin­i­cal de­vel­op­ment, lays off most work­ers

Last month
People

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Last month

FDA clears clin­i­cal tri­al of gene-edit­ed pig liv­er used out­side of body

Last month

Mer­ck ex­plores po­ten­tial of oral pep­tides in deal with Aus­tri­an biotech

Last month
Deals

Sid­dhartha Mukher­jee’s cell ther­a­py start­up nar­rows fo­cus as staff shrinks

Last month
Cell/Gene Tx

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

Last month
Pharma
Manufacturing

Bris­tol My­ers says Camzyos fails Phase 3 study in ge­net­ic heart con­di­tion

Last month
Pharma

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

Last month
Pharma
FDA+

Pri­mate re­searchers cope with un­cer­tain­ty as NIH ap­peals for pay­ment cuts in court 

Last month
Pharma
In Focus

Verve un­veils ear­ly da­ta from sec­ond at­tempt at heart dis­ease gene edit­ing

Last month
Cell/Gene Tx

In a blow to its obe­si­ty pipeline, Pfiz­er drops oral drug af­ter liv­er in­jury case

Last month

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Last month
FDA+

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

Last month
FDA+

Tome Bio founders wran­gle ‘jump­ing genes’ to cre­ate new pro­gram­ma­ble gene in­ser­tion tool

Last month

J&J, ar­genx keep rolling out myas­the­nia gravis da­ta, plus more from #AAN25

Last month
First page Previous page 1234567 Next page Last page
A service from the Financial Times